SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-008790
Filing Date
2020-01-30
Accepted
2020-01-30 17:07:06
Documents
1
Period of Report
2020-01-27

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 12444
  Complete submission text file 0001104659-20-008790.txt   15565
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 175 W. JACKSON BLVD., SUITE 1700 501 PLAZA 2 CHICAGO IL 60604
Business Address 175 W. JACKSON BLVD., SUITE 1700 CHICAGO IL 60604 484-562-1253
G1 EXECUTION SERVICES, LLC (Reporting) CIK: 0001136305 (see all company filings)

State of Incorp.: IL
Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 20562219

Mailing Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004
Business Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004 610-617-2600
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (Reporting) CIK: 0001446179 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 20562220

Mailing Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004
Business Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004 610-617-2600
SUSQUEHANNA SECURITIES, LLC (Reporting) CIK: 0001446580 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 20562221